Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Heron Therapeutics Inc (HRTX) – Heron Therapeutics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Heron Therapeutics (HRTX) trades at $1.19, showing no change recently. The stock exhibits a bullish technical signal with strong moving average support, though RSI levels indicate overbought conditions. Fundamentally, the company reported $155 million in 2025 revenue with a net loss of $20 million, but achieved 65% year-over-year growth in its acute care franchise. Analyst consensus is unanimously positive with 19 buy ratings.
The outlook remains optimistic given strong revenue guidance of $173–$183 million for 2026 and projected positive adjusted EBITDA. Key risks include continued negative earnings and high valuation multiples. The stock's performance hinges on execution against guidance and achieving profitability targets.
Read full analysis

Key Stats

  • Market Cap
    $224.36M
  • Sector
    Health
  • 3M Drawdown
    -45.95%
  • Enterprise Value
    $319.42M
  • Dividend Yield
    -
  • Trading Activity
    58% Buy | 42% Sell
  • Typical Hold Time
    14 days
$1.22
52W Low: $0.75
30 Mar 2026
52W High: $2.42
06 May 2025

Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $224.36M, with an enterprise value of $319.42M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.75 and a high of $2.42, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -45.95%, reflecting recent price volatility. On average, investors hold Heron Therapeutics Inc for approximately 14 days, indicating typical investor behavior on the platform.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (3)Bullish (9)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $224.36M
  • Sector
    Health
  • 3M Drawdown
    -45.95%
  • Enterprise Value
    $319.42M
  • Dividend Yield
    -
  • Trading Activity
    58% Buy | 42% Sell
  • Typical Hold Time
    14 days
$1.22
52W Low: $0.75
30 Mar 2026
52W High: $2.42
06 May 2025

Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $224.36M, with an enterprise value of $319.42M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.75 and a high of $2.42, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -45.95%, reflecting recent price volatility. On average, investors hold Heron Therapeutics Inc for approximately 14 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!